FundingPayments

Correlia Biosystems: Raises $7M in Series A Funding

  • Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
  • The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
  • NeoTribe Ventures joins Correlia’s board of directors as part of the financing
  • The company also intends to use the funds for the commercial launch of its immunoassay platform
  • This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
  • Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics
Previous article
Shinhan Bank: Enhanced Cooperations with partners in diversified fields
Next article
Alliance Data: Completes Acquisition of Bread
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Banking

Why the World’s Wealthiest Are Diversifying Across Borders

London — 18th March 2026 — Global Citizen Solutions (“GCS”), a leading advisory firm in citizenship and residency...
FinTech

Marquis Software Confirms Data Theft of 672K Bank Customers in Ransomware Attack

The cyberattack raises concerns about data security in the banking sector.Highlights: Marquis Software data breach impacts 672,000 bank...
FinTech

NCR Strengthens Focus by Offloading Japanese Bank Technology Business to NTT Data

NCR transfers its Japanese banking tech operations to enhance strategic focus.Highlights: NCR sells its Japanese banking technology business...
FinTech

Agentic Workforce Initiative Enhances Financial Institutions’ Performance

New platform aims to optimize operations for banks and financial service providers.Highlights: New Agentic Workforce initiative launched for...